Tanruprubart, anti-C1q therapy, Accelerates Recovery and Reduces Ventilation in Severe Guillain-Barr&#233; Syndrome: Results from the Phase 3 GBS-02 Trial

tanruprubart (ANX005) - Annexon Biosci

https://onlinelibrary.wiley.com/doi/10.1111/ene.70629

H. Kroon 1; G. Morrison 1; E. Pulkstenis 1; Q. Deen Mohammad 2; K. Gorson 3

Jun 12, 2026